290 related articles for article (PubMed ID: 25339771)
21. Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.
Zhang H; Morgan-Capner P; Latif N; Pandolfino YA; Fan W; Dunn MJ; Archard LC
Am J Pathol; 1997 Jun; 150(6):2197-207. PubMed ID: 9176409
[TBL] [Abstract][Full Text] [Related]
22. Coxsackievirus B3 replication and pathogenesis.
Garmaroudi FS; Marchant D; Hendry R; Luo H; Yang D; Ye X; Shi J; McManus BM
Future Microbiol; 2015; 10(4):629-53. PubMed ID: 25865198
[TBL] [Abstract][Full Text] [Related]
23. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response.
Dai Q; He X; Yu H; Bai Y; Jiang L; Sheng H; Peng J; Wang M; Yu J; Zhang K
J Med Virol; 2021 Jun; 93(6):3581-3589. PubMed ID: 33336842
[TBL] [Abstract][Full Text] [Related]
24. Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections.
Maciejewski S; Nguyen JH; Gómez-Herreros F; Cortés-Ledesma F; Caldecott KW; Semler BL
mBio; 2015 Dec; 7(1):e01931-15. PubMed ID: 26715620
[TBL] [Abstract][Full Text] [Related]
25. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.
Dunn JJ; Chapman NM; Tracy S; Romero JR
J Virol; 2000 May; 74(10):4787-94. PubMed ID: 10775617
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy.
Ruiz AJ; Hadac EM; Nace RA; Russell SJ
J Virol; 2016 Apr; 90(8):4078-4092. PubMed ID: 26865716
[TBL] [Abstract][Full Text] [Related]
27. MiR-126 promotes coxsackievirus replication by mediating cross-talk of ERK1/2 and Wnt/β-catenin signal pathways.
Ye X; Hemida MG; Qiu Y; Hanson PJ; Zhang HM; Yang D
Cell Mol Life Sci; 2013 Dec; 70(23):4631-44. PubMed ID: 23811937
[TBL] [Abstract][Full Text] [Related]
28. FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses.
Xue YC; Ng CS; Mohamud Y; Fung G; Liu H; Bahreyni A; Zhang J; Luo H
J Virol; 2021 May; 95(12):. PubMed ID: 33827951
[TBL] [Abstract][Full Text] [Related]
29. Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.
Lévêque N; Garcia M; Bouin A; Nguyen JHC; Tran GP; Andreoletti L; Semler BL
J Virol; 2017 Aug; 91(16):. PubMed ID: 28539455
[TBL] [Abstract][Full Text] [Related]
30. In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell
Kraft L; Sauter M; Seebohm G; Klingel K
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578416
[TBL] [Abstract][Full Text] [Related]
31. A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts.
Yuan J; Cheung PK; Zhang H; Chau D; Yanagawa B; Cheung C; Luo H; Wang Y; Suarez A; McManus BM; Yang D
Lab Invest; 2004 Jun; 84(6):703-14. PubMed ID: 15094712
[TBL] [Abstract][Full Text] [Related]
32. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
[TBL] [Abstract][Full Text] [Related]
33. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
[TBL] [Abstract][Full Text] [Related]
34. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
Knowlton KU; Jeon ES; Berkley N; Wessely R; Huber S
J Virol; 1996 Nov; 70(11):7811-8. PubMed ID: 8892902
[TBL] [Abstract][Full Text] [Related]
35. MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region.
Wang L; Qin Y; Tong L; Wu S; Wang Q; Jiao Q; Guo Z; Lin L; Wang R; Zhao W; Zhong Z
Antiviral Res; 2012 Feb; 93(2):270-279. PubMed ID: 22197249
[TBL] [Abstract][Full Text] [Related]
36. Cytoplasmic redistribution and cleavage of AUF1 during coxsackievirus infection enhance the stability of its viral genome.
Wong J; Si X; Angeles A; Zhang J; Shi J; Fung G; Jagdeo J; Wang T; Zhong Z; Jan E; Luo H
FASEB J; 2013 Jul; 27(7):2777-87. PubMed ID: 23572232
[TBL] [Abstract][Full Text] [Related]
37. Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardiac infection.
Andréoletti L; Hober D; Becquart P; Belaich S; Copin MC; Lambert V; Wattré P
J Med Virol; 1997 Jun; 52(2):206-14. PubMed ID: 9179770
[TBL] [Abstract][Full Text] [Related]
38. Direct and Indirect Effects on Viral Translation and RNA Replication Are Required for AUF1 Restriction of Enterovirus Infections in Human Cells.
Ullmer W; Semler BL
mBio; 2018 Sep; 9(5):. PubMed ID: 30181254
[TBL] [Abstract][Full Text] [Related]
39. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
